FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)

View source ↗

Summary

FDA approved a supplemental application for KEPPRA (levetiracetam) by UCB, Inc., authorizing changes to its labeling and/or indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Keppra (levetiracetam)

Snippet

SUPPL AP for KEPPRA (LEVETIRACETAM)